Biotech and Pharmaceuticals Life Sciences

  • LONDON, Sept 21- Patients who take medicines derived from blood plasma or urine are not at increased risk of catching Zika, even if the body fluids come from countries where the virus is prevalent, Europe's drugs regulator said on Wednesday. The European Medicines Agency, Europe's equivalent of the U.S. Food and Drug Administration, said its experts had assessed...

  • Sept 19- Bowing to pressure from patient advocates, the U.S. Food and Drug Administration on Monday approved a treatment for Duchenne muscular dystrophy even though an outside panel of experts and the agency's own reviewers questioned the drug's efficacy. The FDA's lead reviewer, Dr. In an email to staff on Monday, Woodcock said the approval "reflects FDA's...

  • Sept 14- GlaxoSmithKline's experimental vaccine to prevent the intensely painful condition known as shingles remained 90 percent effective in people over age 70 even four years after receiving the injection, according to data published on Wednesday. The latest four-year data on Shingrix, which appears in the New England Journal of Medicine, shows it may...

  • Scientists create life without an egg

    Biologists were able to breed baby mice by injecting sperm into a non-viable type of embryo.

  • WASHINGTON, Aug 30- The U.S. Food and Drug Administration on Tuesday approved Novartis AG's biosimilar version of Amgen Inc's arthritis drug Enbrel. The FDA approved the drug, Erelzi, known also as etanercept-szzs, for multiple inflammatory conditions including rheumatoid arthritis and plaque psoriasis, a skin condition. "We are committed to bringing Erelzi...

  • CHICAGO/ TAMPA, Fla., Aug 26- The U.S. Food and Drug Administration recommended on Friday that all blood donated in the United States and its territories be tested for Zika virus, as it moves to prevent transmission of the virus through the blood supply. The agency said its decision to expand blood screening in the United States was based on concerns about more cases...

  • CHICAGO, Aug 26- The U.S. Food and Drug Administration recommended on Friday that all blood donated in the United States and its territories be tested for Zika virus, as it moves to prevent transmission of the virus through the blood supply. The agency said its move to expand blood screening in the United States was based on concerns about increasing cases of local...

  • Executive Edge: Science behind earworms

    David Poeppel, New York University professor, explains why some songs are likely to stick in you mind than others.

  • Aug 8- Mesoblast Ltd on Monday said its experimental stem-cell treatment led to significant improvements of symptoms and disease activity in patients whose rheumatoid arthritis had stopped being helped by widely used biotech medicines, according to data from a mid-stage trial. Treatment with the Australian company's mesenchymal precursor cell product,...

  • Shares of Bristol-Myers fell almost 16 percent to $63.54 on Friday after the company announced failure of the late-stage trial. Shares of Merck gained 8.7 percent to $62.89. "This is the worst-case scenario" for Opdivo and Bristol-Myers, Leerink analyst Seamus Fernandez said in a research note.

  • Health care and life sciences lead Merck's lifted full-year guidance

    Marcus Kuhnert, the chief financial officer of Merck, comments on the company's earnings report and explains which areas of the business are doing well.

  • U.S. concerns over Zika, which is spreading rapidly in the Americas and has hit Brazil the hardest, have risen since Florida authorities last week reported the first signs of local transmission in the continental United States in a Miami neighborhood. The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health federal...

  • WASHINGTON, Aug 3- U.S. government researchers said on Wednesday they have begun their first clinical trial of a Zika vaccine as concerns over the mosquito-borne virus mount following the first cases of local transmission in the continental United States. The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health...

  • HIV virus in an image taken with transmission electron microscopy.

    A judge ruled that an HIV pill to prevent infection could be funded by the U.K.'s state health service, in a victory for AIDS campaigners.

  • Training to be a Olympic champion

    How does World Olympic champion, Greg Rutherford get ready for important sports events and what did his DNA results show? CNBC takes a look.

  • Is DNA analysis worth it?

    Should sporting professionals, academics or even the average individual get their genetic data analyzed? CNBC investigates.

  • The Athlome Project: Setting its sights on a world record

    The Athlome project is an international joint effort to identify performance genes and genes that may influence the injury and predisposition to injury and illness.

  • Why this Olympic champion got his DNA analyzed

    World Olympic champion, Greg Rutherford explains to CNBC why he had his DNA analyzed, and what it might mean for his training and lifestyle choices.

  • How does genetic testing really work?

    At DNAFit, a genetic testing company, CNBC’s Louisa Bojesen takes a look at the step-by-step process of scientists analyzing and processing genetic data.

  • Greg Rutherford: Only the second UK man to win Olympic long jump gold

    Meet Greg Rutherford: World Olympic champion in long jump, who has managed to jump a record 8.51 meters – the length of almost two cars.